13D/13G Filings - TG THERAPEUTICS INC. (TGTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-10
4:49 pm
Sale
2021-01-3113GTG Therapeutics, Inc.
TGTX
RA Capital Management, L.P.6,361,123
4.700%
-6,427,334decrease
(-50.26%)
Filing
History
2021-02-10
4:34 pm
Purchase
2020-12-3113GEiger BioPharmaceuticals, Inc.
EIGR
RA Capital Management, L.P.289,516
6.400%
289,516increase
(New Position)
Filing
History
2021-02-10
11:57 am
Purchase
2020-12-3113GTG Therapeutics, Inc.
TGTX
The Vanguard Group10,970,863
8.110%
10,970,863increase
(New Position)
Filing
History
2021-02-08
10:33 am
Purchase
2021-02-0513GTG Therapeutics, Inc.
TGTX
FMR LLC14,827,136
10.963%
2,179,411increase
(+17.23%)
Filing
History
2021-02-01
08:30 am
Purchase
2020-12-3113GTG Therapeutics, Inc.
TGTX
BlackRock Inc.
BLK
8,556,286
6.300%
2,527,496increase
(+41.92%)
Filing
History
Goto Prev, 0, 1